期刊文献+

雷公藤多甙片联合口服中药治疗寻常型银屑病43例

Glucosidorum Tripterygll Totorum Tablets combined with Oral Chinese Herbal Medicine in Treating Psoriasis Vulgaris for 43 Cases
下载PDF
导出
摘要 目的观察雷公藤多苷片加自拟方治疗寻常型银屑病的临床疗效。方法选取寻常型银屑病患者83例,采用随机数字表法分成两组。试验组采用雷公藤多苷片加中药方剂,观察组单纯口服雷公藤多苷片。治疗3个月后采用酶联免疫吸附试剂盒检测两组患者外周血IFN-γ、IL-2和IL-17、VEGF水平,观察临床疗效。结果试验组患者IFN-γ,IL-2、IL-17和VEGF的水平较观察组明显下降(P<0.05),试验组有效率显著高于对照组(P<0.01)。结论雷公藤合并本院自拟方剂对银屑病疗效较单一使用雷公藤效果更佳。 Objective To observe the clinical effect of Glucosidorum Tripterygll Totorum tablets combined with oral Chinese herbal medicine in treating psoriasis vulgaris. Methods 83 cases of patients with psoriasis vulgaris were randomly divided into two groups. The experimental group was treated with Glucosidorum Tripterygll Totorum tablets and oral Chinese herbal medicine, and the observation group was simply treated with Glucosidorum Tripterygll Totorum tablets. Three months after treatment, the levels of IFN-γ, IL-2 and IL-17 and VEGF were detected by ELISA kit, and the clinical effect was observed. Results The levels of IFN-γ, IL-2 and IL-17 and VEGF were significantly decreased in the experimental group( P〈0.05), and the efficiency of the experimental group was significantly higher than that of the control group( P 〈0.01). Conclusion The effect of Glucosidorum Tripterygll Totorum tablets combined with self-made prescription was better than.
作者 张锋 卢丽华
出处 《中国中医药现代远程教育》 2015年第16期62-64,共3页 Chinese Medicine Modern Distance Education of China
关键词 银屑病 雷公藤多苷片 中医药疗法 psoriasis vulgaris Glucosidorum Tripterygll Totorum tablets oral Chinese herbal medicine
  • 相关文献

参考文献4

二级参考文献23

  • 1王珏,周志愉,易剑峰,何颖辉,贾红伟,吕爱平.雷公藤免疫调节作用研究进展[J].中国中医基础医学杂志,2006,12(3):230-232. 被引量:23
  • 2王琼玉,阎呼玲,刘平,彭振辉,谭升顺.他扎罗汀对进行期银屑病增殖表皮中早幼粒细胞白血病基因的抑制作用[J].南方医科大学学报,2006,26(8):1146-1148. 被引量:3
  • 3Nickoloff BJ. Cracking the cytokine code in psoria- sis[J].Nat Med, 2007.13(3):242-244.
  • 4Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and the- rapy of psoriasis[J].Nature,2007,445 (7130):866-873.
  • 5Liu H,Liu ZH, Chen ZH,et al. Triptolide:a potent inhi- bitor of NF-κB in T-lymphocytes[J].hcta Pharmacol Sinica,2000,21(9):782-786.
  • 6Tak PP,Firestein GS. NF-xB:A key role in inflamma- tory diseases[J].J clin Invest,2001,107(1):7-11.
  • 7Lee Jang IK,Pharm D, Gibert J,et al. Nuclear factor kappa B:important transcription factor and thera- pentic target[J].J Clin'Pharmacol,1998,38(11):981- 993.
  • 8Christman JW,Lan Caster LH,Black Well TS,et al. Nu- clear factorxB:a piovtal role in the systemic infl- ammory response syndrome and new target for therapy [J].Intensive Care Med, 1998,24:1131-1138.
  • 9D'Acquisto F,May MJ,Ghosh S. Inhibition of nuclear factor kappa B (NF-B):an emerging theme in anti- inflammatory therapies[J].Mol Interv,2002,2(1):22- 35.
  • 10Jing-kang HE,Shu-dong YU,Hong-Jun ZHU,Jun-chaoWU,Zheng-hong QIN.Triptolide inhibits NF-kB activation and reduces injury of donor lung induced by ischemia/reperfusion[J].Acta Pharmacologica Sinica,2007,28(12):1919-1923. 被引量:9

共引文献419

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部